Turku University Hospital, Syöpäklinikka
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Jyrkkiö, Sirkku
POLAR BEAR, NCT04332822 / 2018-003889-14: A Randomized, Multicenter, Phase III Trial Comparing Treatment With R-mini-CHOP With R-mini-CHP + Polatuzumab Vedotin in Patients With Diffuse Large Cell B Cell Lymphoma

Recruiting
3
300
Europe, RoW
R-pola-mini-CHP, R-mini-CHOP
Nordic Lymphoma Group, Roche Pharma AG
DLBCL, Diffuse Large B Cell Lymphoma
12/25
12/28
Bio-CHIC, NCT03293173 / 2015-002846-30: Biomarker Driven Intensified ChemoImmunotherapy With Early CNS Prophylaxis

Active, not recruiting
2
120
Europe
R-CHOEP, DA-EPOCH-R
Nordic Lymphoma Group, Helsinki University Central Hospital, Aarhus University Hospital
Lymphoma, Large B-Cell, Diffuse
01/21
12/24
EXETUMOR, NCT03987724: Exercise and Tumor Blood Flow

Recruiting
N/A
8
Europe
Positron emission tomography (PET) imaging at rest and during supine bicycle exercise
Turku University Hospital
Tumor Blood Flow at Rest and During Exercise
08/24
08/24

Download Options